Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10385135 Subcutaneous formulations of anti-CD38 antibodies and their uses

Patent 10385135 was granted and assigned to Janssen Biotech on August, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Janssen Biotech

0

Current Assignee

Janssen Biotech

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Richard Jansson0

Vineet Kumar0

Date of Patent

August 20, 2019

0

Patent Application Number

153402900

Date Filed

November 1, 2016

0

Patent Citations Received

US Patent 12091466 Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies

0

US Patent 11618787 Methods of treating high risk multiple myeloma

0

US Patent 11708420 Subcutaneous formulations of anti-CD38 antibodies and their uses

0

US Patent 11708419 Subcutaneous formulations of anti-CD38 antibodies and their uses

0

US Patent 11713355 Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia

0

US Patent 12060432 Combination therapies with anti-CD38 antibodies

0

US Patent 10556961 Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia

US Patent 10604580 Combination therapies with anti-CD38 antibodies

...

Patent Primary Examiner

Jessica H Roark

0

Patent abstract

The present invention relates to subcutaneous formulations of anti-CD38 antibodies and their uses.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10385135 Subcutaneous formulations of anti-CD38 antibodies and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.